C. Hasse et al., ISOTRANSPLANTATION OF MICROENCAPSULATED PARATHYROID TISSUE IN RATS, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 105(1), 1997, pp. 53-56
Permanent hypoparathyroidism is one of the most difficult of all endoc
rine disorders to treat medically. While autotransplantation of parath
yroid tissue is clinically established, allotransplantation without im
munosuppression is still at the level of animal experiments. Although
persons affected by hypoparathyroidism are facing a clearly reduced qu
ality of life, hypoparathyroidism rarely is a life threatening conditi
on. Therefore, systemic immunosuppression for recipients of allotransp
lants is not justified. A conceptional alternative would be protecting
the tissue to be transplanted from the immunologic response by coatin
g it with a semipermeable membrane (microencapsulation). In 1994, we s
ucceeded in iso-, allo- and xenotransplantation of microencapsulated p
arathyroid tissue in an animal model. Unfortunately, prior to the firs
t clinical use, further analysis of the coating substance (alginate) d
emonstrated that it has mitogenic properties. Here, we report on the f
irst successful transplantation of microencapsulated parathyroid tissu
e using a purified, non-mitogenic alginate which is suitable for clini
cal use.